+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Medical Hyperspectral Imaging Market by Application, Product Type End User: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 161 Pages
  • November 2021
  • Region: Global
  • Allied Market Research
  • ID: 5533775
Description Jump to:
The global medical hyperspectral imaging market was valued at $ 272.10 million in 2020, and is projected to reach $ 408.80 million by 2030 registering a CAGR of 4.10% from 2021 to 2030.

Hyperspectral imaging is a sort of imaging technology that combines spectroscopy and digital imaging capabilities. This imaging approach is recognized to produce a better image than a standard camera and to classify items in the scene based on their spectral features. It is utilized for a variety of things, including geospatial exploration and oil spill monitoring and detection, among other things.

HSI, as a new imaging modality for medical use, offers great potential for noninvasive disease diagnosis and surgical guidance. As light passes through biological tissue, it is scattered numerous times due to inhomogeneity of biological structures and is absorbed predominantly by hemoglobin, melanin, and water. The absorption, fluorescence, and scattering characteristics of tissue are thought to vary as disease progresses. As a result, HSI uses reflected, fluorescence, and transmitted light from tissue to acquire quantitative diagnostic information about tissue disease.

The market is driven by rise in awareness, coupled with safety and ease of use of HSI systems, advanced medical imaging capabilities, and growth in adoption of HSI imaging systems. In addition, increasing awareness, coupled with safety and ease of use of HSI systems is anticipated to boost growth of the market as well. However high cost of investments and insufficiency of medical infrastructure to support these devices restrain growth of the medical hyperspectral imaging market.

The report segments the medical hyperspectral imaging market on the basis of application, end user and region. According to the application, the market is classified into medical diagnostics, image guided surgery and other. Based on product type market is bifurcated into camera and accessories. Furthermore, under end user segmentation diagnostic centers, hospitals and research centers are included. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America accounted for a major share in the medical hyperspectral imaging market in 2020, and is expected to maintain its dominance during the forecast period, owing to presence of well-established healthcare systems in the U.S. and Canada, increasing funding and investments, growing industrial applications of hyperspectral imaging, and advancements in hardware and software for image processing and analysis. In addition, improvement in healthcare infrastructure and increasing demand for accuracy of surgical procedures are anticipated to boost the medical hyperspectral imaging market during the forecast period.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the global medical hyperspectral imaging market along with the current trends and future estimations to elucidate imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps understand the end users and products of medical hyperspectral imaging used across the globe.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the market.


KEY MARKET SEGMENTS

  • Application
  • Cancer Diagnostics
  • Image Guided Surgery
  • Others
  • Product Type
  • Camera
  • Accessories

By End User

  • Diagnostic Centers
  • Hospitals
  • Research Centers

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top winning strategies
3.3. Porter’s five force analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increase in R&D in the medical field
3.5.1.2. Increase in number of chronic diseases
3.5.2. Restraint
3.5.2.1. High cost and low frame rate of hyperspectral imaging systems
3.5.3. Opportunity
3.5.3.1. Growth opportunities in emerging economies
3.5.4. Impact analysis
3.6. COVID-19 impact analysis on the medical hyperspectral imaging market
CHAPTER 4: MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Cancer Detection
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Image Guided Surgery
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Others
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
CHAPTER 5: MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Camera
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Accessories
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
CHAPTER 6: MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Diagnostic Centers
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Hospitals
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Research Centers
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
CHAPTER 7: MEDICAL HYPERSPECTRAL IMAGING MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast, by region
7.2. North America
7.2.1. Key trends and growth opportunities
7.2.2. Market size and forecast, by application
7.2.3. Market size and forecast, by product type
7.2.4. North America Market size and forecast, by end user
7.2.5. North America Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.2. U.S. Market size and forecast, by application
7.2.5.3. U.S. Market size and forecast, by product type
7.2.5.4. U.S. Market size and forecast, by end user
7.2.5.5. Canada
7.2.5.6. Canada Market size and forecast, by application
7.2.5.7. Canada Market size and forecast, by product type
7.2.5.8. Canada Market size and forecast, by end user
7.2.5.9. Mexico
7.2.5.10. Mexico Market size and forecast, by application
7.2.5.11. Mexico Market size and forecast, by product type
7.2.5.12. Mexico Market size and forecast, by end user
7.3. Europe
7.3.1. Key trends and growth opportunities
7.3.2. Europe Market size and forecast, by application
7.3.3. Europe Market size and forecast, by product type
7.3.4. Europe Market size and forecast, by end user
7.3.5. Europe Market size and forecast, by country
7.3.5.1. Germany
7.3.5.2. Germany Market size and forecast, by application
7.3.5.3. Germany Market size and forecast, by product type
7.3.5.4. Germany Market size and forecast, by end user
7.3.5.5. France
7.3.5.6. France Market size and forecast, by application
7.3.5.7. France Market size and forecast, by product type
7.3.5.8. France Market size and forecast, by end user
7.3.5.9. UK
7.3.5.10. UK Market size and forecast, by application
7.3.5.11. UK Market size and forecast, by product type
7.3.5.12. UK Market size and forecast, by end user
7.3.5.13. Italy
7.3.5.14. Italy Market size and forecast, by application
7.3.5.15. Italy Market size and forecast, by product type
7.3.5.16. Italy Market size and forecast, by end user
7.3.5.17. Spain
7.3.5.18. Spain Market size and forecast, by application
7.3.5.19. Spain Market size and forecast, by product type
7.3.5.20. Spain Market size and forecast, by end user
7.3.5.21. Rest of Europe
7.3.5.22. Rest of Europe Market size and forecast, by application
7.3.5.23. Rest of Europe Market size and forecast, by product type
7.3.5.24. Rest of Europe Market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key trends and growth opportunities
7.4.2. Asia-Pacific Market size and forecast, by application
7.4.3. Asia-Pacific Market size and forecast, by product type
7.4.4. Asia-Pacific Market size and forecast, by end user
7.4.5. Asia-Pacific Market size and forecast, by country
7.4.5.1. Japan
7.4.5.2. Japan Market size and forecast, by application
7.4.5.3. Japan Market size and forecast, by product type
7.4.5.4. Japan Market size and forecast, by end user
7.4.5.5. China
7.4.5.6. China Market size and forecast, by application
7.4.5.7. China Market size and forecast, by product type
7.4.5.8. China Market size and forecast, by end user
7.4.5.9. India
7.4.5.10. India Market size and forecast, by application
7.4.5.11. India Market size and forecast, by product type
7.4.5.12. India Market size and forecast, by end user
7.4.5.13. Australia
7.4.5.14. Australia Market size and forecast, by application
7.4.5.15. Australia Market size and forecast, by product type
7.4.5.16. Australia Market size and forecast, by end user
7.4.5.17. South Korea
7.4.5.18. South Korea Market size and forecast, by application
7.4.5.19. South Korea Market size and forecast, by product type
7.4.5.20. South Korea Market size and forecast, by end user
7.4.5.21. Rest of Asia-Pacific
7.4.5.22. Rest of Asia-Pacific Market size and forecast, by application
7.4.5.23. Rest of Asia-Pacific Market size and forecast, by product type
7.4.5.24. Rest of Asia-Pacific Market size and forecast, by end user
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. LAMEA Market size and forecast, by application
7.5.3. LAMEA Market size and forecast, by product type
7.5.4. LAMEA Market size and forecast, by end user
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.2. Brazil Market size and forecast, by application
7.5.5.3. Brazil Market size and forecast, by product type
7.5.5.4. Brazil Market size and forecast, by end user
7.5.5.5. Saudi Arabia
7.5.5.6. Saudi Arabia Market size and forecast, by application
7.5.5.7. Saudi Arabia Market size and forecast, by product type
7.5.5.8. Saudi Arabia Market size and forecast, by end user
7.5.5.9. South Africa
7.5.5.10. South Africa Market size and forecast, by application
7.5.5.11. South Africa Market size and forecast, by product type
7.5.5.12. South Africa Market size and forecast, by end user
7.5.5.13. Rest of LAMEA
7.5.5.14. Rest of LAMEA Market size and forecast, by application
7.5.5.15. Rest of LAMEA Market size and forecast, by product type
7.5.5.16. Rest of LAMEA Market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. Clyde HSI
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.2. Cubert-GmbH
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Key strategic moves and developments
8.3. Diaspective Vision
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.4. Headwall Photonics Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Key strategic moves and developments
8.5. imec
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Key strategic moves and developments
8.6. Konica Minolta (Specim Spectral Imaging Ltd.)
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. Norsk Elektro Optikk A/S
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.8. Resonon, Inc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.9. Surface Optics Corporation
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.10. Ximea
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Key strategic moves and developments
List of Tables
TABLE 01. MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 02. MEDICAL HYPERSPECTRAL IMAGING MARKET FOR CANCER DETECTION, BY REGION, 2020-2030 ($MILLION)
TABLE 03. MEDICAL HYPERSPECTRAL IMAGING MARKET FOR IMAGE GUIDED SURGERY, BY REGION, 2020-2030 ($MILLION)
TABLE 04. MEDICAL HYPERSPECTRAL IMAGING MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 05. MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 06. MEDICAL HYPERSPECTRAL IMAGING MARKET FOR CAMERA, BY REGION, 2020-2030($MILLION)
TABLE 07. MEDICAL HYPERSPECTRAL IMAGING MARKET FOR ACCESSORIES, BY REGION, 2020-2030($MILLION)
TABLE 08. MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER, 2020-2030($MILLION)
TABLE 09. MEDICAL HYPERSPECTRAL IMAGING MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2020-2030($MILLION)
TABLE 10. MEDICAL HYPERSPECTRAL IMAGING MARKET FOR HOSPITALS, BY REGION, 2020-2030($MILLION)
TABLE 11. MEDICAL HYPERSPECTRAL IMAGING MARKET FOR RESEARCH CENTERS, BY REGION, 2020-2030($MILLION)
TABLE 12. MEDICAL HYPERSPECTRAL IMAGING MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 13. NORTH AMERICA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 14. NORTH AMERICA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 15. NORTH AMERICA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 16. NORTH AMERICA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 17. U.S. MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 18. U.S. MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 19. U.S. MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 20. CANADA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 21. CANADA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 22. CANADA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 23. MEXICO MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 24. MEXICO MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 25. MEXICO MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 26. EUROPE MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 27. EUROPE MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 28. EUROPE MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 29. EUROPE MEDICAL HYPERSPECTRAL IMAGING MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 30. GERMANY MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 31. GERMANY MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 32. GERMANY MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 33. FRANCE MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 34. FRANCE MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 35. FRANCE MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 36. UK MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 37. UK MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 38. UK MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 39. ITALY MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 40. ITALY MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 41. ITALY MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 42. SPAIN MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 43. SPAIN MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 44. SPAIN MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 45. REST OF EUROPE MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 46. REST OF EUROPE MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 47. REST OF EUROPE MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 48. ASIA-PACIFIC MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 49. ASIA-PACIFIC MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 50. ASIA-PACIFIC MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 51. ASIA-PACIFIC MEDICAL HYPERSPECTRAL IMAGING MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 52. JAPAN MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 53. JAPAN MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 54. JAPAN MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 55. CHINA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 56. CHINA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 57. CHINA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 58. INDIA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 59. INDIA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 60. INDIA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 61. AUSTRALIA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 62. AUSTRALIA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 63. AUSTRALIA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 64. SOUTH KOREA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 65. SOUTH KOREA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 66. SOUTH KOREA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 67. REST OF ASIA-PACIFIC MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 70. LAMEA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 71. LAMEA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 72. LAMEA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 73. LAMEA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 74. BRAZIL MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 75. BRAZIL MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 76. BRAZIL MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 77. SAUDI ARABIA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 78. SAUDI ARABIA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 79. SAUDI ARABIA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 80. SOUTH AFRICA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 81. SOUTH AFRICA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 82. SOUTH AFRICA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 83. REST OF LAMEA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 84. REST OF LAMEA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 85. REST OF LAMEA MEDICAL HYPERSPECTRAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 86. CLYDE HSI: COMPANY SNAPSHOT
TABLE 87. CLYDE HSI: PRODUCT SEGMENTS
TABLE 88. CLYDE HSI: PRODUCT PORTFOLIO
TABLE 89. CUBERT: COMPANY SNAPSHOT
TABLE 90. CUBERT: OPERATING SEGMENTS
TABLE 91. CUBERT: PRODUCT PORTFOLIO
TABLE 92. CUBERT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 93. DIASPECTIVE VISION: COMPANY SNAPSHOT
TABLE 94. DIASPECTIVE VISION: OPERATING SEGMENTS
TABLE 95. DIASPECTIVE VISION: PRODUCT PORTFOLIO
TABLE 96. HEADWALL PHOTONICS: COMPANY SNAPSHOT
TABLE 97. HEADWALL PHOTONICS: OPERATING SEGMENTS
TABLE 98. HEADWALL PHOTONICS: PRODUCT PORTFOLIO
TABLE 99. HEADWALL PHOTONICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100. IMEC: COMPANY SNAPSHOT
TABLE 101. IMEC: OPERATING SEGMENTS
TABLE 102. IMEC: PRODUCT PORTFOLIO
TABLE 103. IMEC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 104. KONICA MINOLTA: COMPANY SNAPSHOT
TABLE 105. KONICA MINOLTA: OPERATING SEGMENTS
TABLE 106. KONICA MINOLTA: PRODUCT PORTFOLIO
TABLE 107. KONICA MINOLTA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 108. NEO: COMPANY SNAPSHOT
TABLE 109. NEO: OPERATING SEGMENTS
TABLE 110. NEO: PRODUCT PORTFOLIO
TABLE 111. RESONON: COMPANY SNAPSHOT
TABLE 112. RESONON: OPERATING SEGMENTS
TABLE 113. RESONON: PRODUCT PORTFOLIO
TABLE 114. SURFACE OPTICS: COMPANY SNAPSHOT
TABLE 115. SURFACE OPTICS: OPERATING SEGMENTS
TABLE 116. SURFACE OPTICS: PRODUCT PORTFOLIO
TABLE 117. XIMEA: COMPANY SNAPSHOT
TABLE 118. XIMEA: OPERATING SEGMENTS
TABLE 119. XIMEA: PRODUCT PORTFOLIO
TABLE 120. XIMEA: KEY STRATEGIC MOVES AND DEVELOPMENTS
List of Figures
FIGURE 01. MEDICAL HYPERSPECTRAL IMAGING MARKET SEGMENTATION
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021 (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07. LOW BARGAINING POWER OF BUYERS
FIGURE 08. LOW THREAT OF SUBSTITUTES
FIGURE 09. HIGH THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE INTENSITY OF RIVALRY
FIGURE 11. TOP PLAYER POSITIONING, 2020
FIGURE 12. IMPACT ANALYSIS
FIGURE 13. COMPARATIVE ANALYSIS OF MEDICAL HYPERSPECTRAL IMAGING MARKET FOR CANCER DETECTION, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14. COMPARATIVE ANALYSIS OF MEDICAL HYPERSPECTRAL IMAGING MARKET IMAGE GUIDED SURGERY, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 15. COMPARATIVE ANALYSIS OF MEDICAL HYPERSPECTRAL IMAGING MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 16. COMPARATIVE ANALYSIS OF MEDICAL HYPERSPECTRAL IMAGING MARKET FOR CAMERA, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 17. COMPARATIVE ANALYSIS OF MEDICAL HYPERSPECTRAL IMAGING MARKET FOR ACCESSORIES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18. COMPARATIVE ANALYSIS OF MEDICAL HYPERSPECTRAL IMAGING MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19. COMPARATIVE ANALYSIS OF MEDICAL HYPERSPECTRAL IMAGING MARKET FOR HOSPITALS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20. COMPARATIVE ANALYSIS OF MEDICAL HYPERSPECTRAL IMAGING MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21. KONICA MINOLTA: NET SALES, 2018–2020 ($MILLION)
FIGURE 22. KONICA MINOLTA: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 23. KONICA MINOLTA: REVENUE SHARE, BY REGION, 2020 (%)

Companies Mentioned

  • ClydeHSI
  • Cubert Diaspective Vision GmbH
  • Headwall Photonics Inc.
  • Specim Spectral Imaging Ltd.
  • Imec
  • Norsk Elektro Optikk A/S Resonon Inc.
  • Surface Optics Corp
  • Ximea

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages161
PublishedNovember 2021
Forecast Period2020 - 2030
Estimated Market Value ( USD ) in 2020 $ 272.1 million
Forecasted Market Value ( USD ) by 2030 $ 408.8 million
Compound Annual Growth Rate4.2%
Regions CoveredGlobal
No. of Companies Mentioned8

Related Topics

Related Reports

Global Medical Hyperspectral Imaging Systems Market Analysis Report by Product (Hyperspectral Camera, Accessories), Technology (Snapshot, Push Broom, Others), Application, End-use, and Segment Forecasts, 2024-2030 - Product Image

Global Medical Hyperspectral Imaging Systems Market Analysis Report by Product (Hyperspectral Camera, Accessories), Technology (Snapshot, Push Broom, Others), Application, End-use, and Segment Forecasts, 2024-2030

  • Report
  • 195 Pages
  • Global
From
Hyperspectral Imaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Image

Hyperspectral Imaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • 171 Pages
  • Global
From
Hyperspectral Imaging Systems Market by Product (Camera, Accessories), Technology (Snapshot, Pushbroom), Application (Military, Remote Sensing (Agriculture, Environmental), Machine Vision, Life Sciences & Diagnostics) & Region-Global Forecast to 2028 - Product Image

Hyperspectral Imaging Systems Market by Product (Camera, Accessories), Technology (Snapshot, Pushbroom), Application (Military, Remote Sensing (Agriculture, Environmental), Machine Vision, Life Sciences & Diagnostics) & Region-Global Forecast to 2028

  • Report
  • 199 Pages
  • Global
From
Hyperspectral Imaging Systems - Global Strategic Business Report - Product Image

Hyperspectral Imaging Systems - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Global Hyperspectral Imaging Systems Market by Product (Accessories, Cameras), Technology (Push Broom, Snapshot), Application - Forecast 2024-2030 - Product Image

Global Hyperspectral Imaging Systems Market by Product (Accessories, Cameras), Technology (Push Broom, Snapshot), Application - Forecast 2024-2030

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.